Copertina

Long‐Term Safety Evaluations in the Presence of Switching: Evaluation of Two Approaches

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sandra Schmeller, Rima Izem, Pedro Lopez Romero, Valentine Jehl
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmaceutical Statistics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Evaluating Safety Rules in Ongoing Dose‐Escalation Trials Using BOIN : A Comparative Analysis of Criteria and Their Impact on Dose‐Level Safety Assessments
di: Stefan Englert, et al.
Pubblicazione: (2026)

A Federated Data Analysis Approach for the Evaluation of Surrogate Endpoints
di: Dries De Witte, et al.
Pubblicazione: (2025)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
di: Anders Granholm, et al.
Pubblicazione: (2025)

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions
di: Cesar Torres, et al.
Pubblicazione: (2025)

Leveraging Two‐Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models
di: Marina Cuquerella‐Gilabert, et al.
Pubblicazione: (2026)

Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk–Benefit Analysis
di: Utkarsh Chauhan, et al.
Pubblicazione: (2025)

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding
di: Douglas Faries, et al.
Pubblicazione: (2024)

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data
di: Carl‐Fredrik Burman, et al.
Pubblicazione: (2024)

Predictive Biomarker Graphical Approach ( PRIME ) for Precision Medicine
di: Gina D’Angelo, et al.
Pubblicazione: (2026)

A practical guide to the appropriate analysis of eGFR data over time: A simulation study
di: Todd DeVries, et al.
Pubblicazione: (2024)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
di: Zhiwei Zhang, et al.
Pubblicazione: (2025)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
di: Ping Gao, et al.
Pubblicazione: (2025)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
di: Chiara Micoli, et al.
Pubblicazione: (2025)

Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification Bias
di: Sihan Jia, et al.
Pubblicazione: (2026)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
di: Ryo Kitabayashi, et al.
Pubblicazione: (2025)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
di: Gina D'Angelo, et al.
Pubblicazione: (2025)

The Estimand Framework and Causal Inference: Complementary Not Competing Paradigms
di: Thomas Drury, et al.
Pubblicazione: (2025)

Confidence Intervals for Validation of Analytical Procedures Under ICH Q2 ( R2 )
di: Paul Faya, et al.
Pubblicazione: (2025)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
di: Heng Li, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
di: Xiaolong Luo, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
di: Heather J. Litman, et al.
Pubblicazione: (2025)

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations
di: Saurabh Mukhopadhyay, et al.
Pubblicazione: (2025)

Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources
di: Keita Takahashi, et al.
Pubblicazione: (2025)

A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design
di: Qingyang Zhang, et al.
Pubblicazione: (2025)

Extending Multiple Testing With Unknown Test Dependency via the CoCo Test: With Applications to Cancer Studies
di: Jiangtao Gou, et al.
Pubblicazione: (2025)

Why “Minimal Clinically Important Difference” for Interpreting the Magnitude of the Treatment Effect Is Not Useful
di: Jitendra Ganju
Pubblicazione: (2025)

Finding the Optimal Number of Splits and Repetitions in Double Cross‐Fitting Targeted Maximum Likelihood Estimators
di: Mohammad Ehsanul Karim, et al.
Pubblicazione: (2025)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
di: Dario Zocholl, et al.
Pubblicazione: (2025)

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
di: Jerome Sepin, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Average Hazard as Harmonic Mean
di: Yasutaka Chiba
Pubblicazione: (2025)

Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data
di: Max Menssen, et al.
Pubblicazione: (2025)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
di: Tomoyoshi Hatayama, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

The Wilcoxon–Mann–Whitney Estimand Versus Differences in Medians or Means
di: Linda J. Harrison, et al.
Pubblicazione: (2025)

A Tree‐Based Scan Statistic for Detecting Signals of Drug–Drug Interactions in Spontaneous Reporting Databases
di: Seok‐Jae Heo, et al.
Pubblicazione: (2025)

Mediation Analysis of Path‐Specific Effects in Randomised Clinical Trials With Repeatedly Measured Mediators and Outcomes
di: Martin Linder, et al.
Pubblicazione: (2025)

Statistical Consideration for Event‐Free Survival With Cure Rate in Acute Myeloid Leukemia Studies
di: Yuichiro Kaneko, et al.
Pubblicazione: (2025)